Found: 24
Select item for more details and to access through your institution.
IL-9 promotes the survival and function of human melanoma-infiltrating CD4<sup>+</sup>CD8<sup>+</sup> double-positive T cells.
- Published in:
- European Journal of Immunology, 2016, v. 46, n. 7, p. 1770, doi. 10.1002/eji.201546061
- By:
- Publication type:
- Article
The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.925241
- By:
- Publication type:
- Article
Oncolytic attenuated measles virus encoding NY-ESO-1 induces HLA I and II presentation of this tumor antigen by melanoma and dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 10, p. 3309, doi. 10.1007/s00262-023-03486-4
- By:
- Publication type:
- Article
Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 10, p. 3015, doi. 10.1007/s00262-021-02961-0
- By:
- Publication type:
- Article
Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1663, doi. 10.1007/s00262-020-02572-1
- By:
- Publication type:
- Article
Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 8, p. 1209, doi. 10.1007/s00262-018-2176-2
- By:
- Publication type:
- Article
A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 4, p. 553, doi. 10.1007/s00262-008-0578-2
- By:
- Publication type:
- Article
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 185, doi. 10.1007/s00262-007-0361-9
- By:
- Publication type:
- Article
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 11, p. 1853, doi. 10.1007/s00262-007-0340-1
- By:
- Publication type:
- Article
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 4, p. 515, doi. 10.1007/s00262-006-0204-0
- By:
- Publication type:
- Article
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 532, doi. 10.1007/s00262-002-0313-3
- By:
- Publication type:
- Article
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 10, p. 539, doi. 10.1007/s00262-002-0315-1
- By:
- Publication type:
- Article
High-scale expansion of melanoma-reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement.
- Published in:
- Cancer Immunology, Immunotherapy, 2001, v. 50, n. 3, p. 134, doi. 10.1007/PL00006683
- By:
- Publication type:
- Article
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1256, doi. 10.3390/cancers13061256
- By:
- Publication type:
- Article
hnRNP‐A1 binds to the IRES of MELOE‐1 antigen to promote MELOE‐1 translation in stressed melanoma cells.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 3, p. 594, doi. 10.1002/1878-0261.13088
- By:
- Publication type:
- Article
Apoptotic body-loaded dendritic cells efficiently cross-prime cytotoxic T lymphocytes specific for NA17-A antigen but not for Melan-A/MART-1 antigen.
- Published in:
- International Journal of Cancer, 2002, v. 101, n. 3, p. 280, doi. 10.1002/ijc.10605
- By:
- Publication type:
- Article
Treatment of Metastatic Melanoma with Autologous Melan-A/Mart-1-Specific Cytotoxic T Lymphocyte Clones.
- Published in:
- Journal of Investigative Dermatology, 2009, v. 129, n. 12, p. 2835, doi. 10.1038/jid.2009.144
- By:
- Publication type:
- Article
CD4CD8αα Lymphocytes, A Novel Human Regulatory T Cell Subset Induced by Colonic Bacteria and Deficient in Patients with Inflammatory Bowel Disease.
- Published in:
- PLoS Biology, 2014, v. 12, n. 4, p. 1, doi. 10.1371/journal.pbio.1001833
- By:
- Publication type:
- Article
Low Levels of Natural Anti-α- N -Acetylgalactosamine (Tn) Antibodies Are Associated With COVID-19.
- Published in:
- Frontiers in Microbiology, 2021, v. 11, p. N.PAG, doi. 10.3389/fmicb.2021.641460
- By:
- Publication type:
- Article
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy.
- Published in:
- European Journal of Immunology, 2010, v. 40, n. 6, p. 1786, doi. 10.1002/eji.200940132
- By:
- Publication type:
- Article
Dominant TCR Vα usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens.
- Published in:
- European Journal of Immunology, 2002, v. 32, n. 11, p. 3181, doi. 10.1002/1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2
- By:
- Publication type:
- Article
Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 7, p. 2007, doi. 10.1002/1521-4141(200107)31:7<2007::AID-IMMU2007>3.0.CO;2-S
- By:
- Publication type:
- Article
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells.
- Published in:
- European Journal of Immunology, 2000, v. 30, n. 3, p. 803, doi. 10.1002/1521-4141(200003)30:3<803::AID-IMMU803>3.0.CO;2-P
- By:
- Publication type:
- Article
LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal.
- Published in:
- European Journal of Immunology, 1998, v. 28, n. 4, p. 1322, doi. 10.1002/(SICI)1521-4141(199804)28:04<1322::AID-IMMU1322>3.0.CO;2-I
- By:
- Publication type:
- Article